Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Medshine Discovery patents new PPAR agonists

Feb. 1, 2018

Acasti initiates TRILOGY trials of CaPre in patients with severe hypertriglyceridemia

Feb. 1, 2018

FDA gives Protalix Biotherapeutics' PRX-102 fast track designation

Feb. 1, 2018

FDA gives orphan drug status to Dauntless Pharmaceuticals' DP-1038 for acromegaly

Jan. 31, 2018

EMA committee recommends approval of biosimilar insulin glargine Semglee

Jan. 31, 2018

Regeneron studies long-term safety and efficacy of evinacumab in patients with HoFH

Jan. 30, 2018

EMA committee recommends approval of Lamzede for alpha-mannosidosis

Jan. 30, 2018

Novel compounds validate nicotinamide-N-methyltransferase as an antiobesity target

Jan. 29, 2018

Acquist patents novel SLC22A12 inhibitors

Jan. 29, 2018

Adocia reports topline results from phase Ib study of BioChaperone Combo

Jan. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...